Search Results - "Chen, Weihsu C"
-
1
Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169
Published in PloS one (19-06-2012)“…Sialoadhesin (Sn, Siglec-1, CD169) is a member of the sialic acid binding Ig-like lectin (siglec) family expressed on macrophages. Its macrophage specific…”
Get full text
Journal Article -
2
Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies
Published in Frontiers in immunology (07-03-2018)“…Therapeutic molecules derived from antibodies have become a dominant class of drugs used to treat human disease. Increasingly, therapeutic antibodies are…”
Get full text
Journal Article -
3
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Published in Nature (London) (15-12-2016)“…A rapid gene signature test (LSC17) that captures stem cell expression programs in acute myeloid leukaemia patients at diagnosis is associated with therapy…”
Get full text
Journal Article -
4
Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
Published in Clinical cancer research (15-01-2018)“…To explore the potential of expanded healthy donor-derived allogeneic CD4 and CD8 double-negative cells (DNT) as a novel cellular immunotherapy for leukemia…”
Get full text
Journal Article -
5
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Published in Blood (10-06-2010)“…Antibody-mediated cell depletion therapy has proven to provide significant clinical benefit in treatment of lymphomas and leukemias, driving the development of…”
Get full text
Journal Article -
6
Noninvasive Imaging of Dendrimer‐Type N‐Glycan Clusters: In Vivo Dynamics Dependence on Oligosaccharide Structure
Published in Angewandte Chemie (International ed.) (25-10-2010)“…Body image: Self‐activating Huisgen 1,3‐dipolar cycloaddition and 6π azaelectrocyclization of lysine‐based dendrimers (see picture) enable the in vivo dynamics…”
Get full text
Journal Article -
7
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22
Published in Leukemia & lymphoma (01-02-2012)“…Abstract CD22 is a member of the siglec (sialic acid-binding immunoglobulin-like lectin) family expressed on B cells that recognizes glycans of glycoproteins…”
Get full text
Journal Article -
8
CellCelector™ as a platform in isolating primary B cells for antibody discovery
Published in Antibody therapeutics (01-01-2022)“…ABSTRACT The most robust strategy in antibody discovery is the use of immunized animals and the ability to isolate and immortalize immune B-cells to hybridoma…”
Get full text
Journal Article -
9
An Integrated Analysis of Heterogeneous Drug Responses in Acute Myeloid Leukemia That Enables the Discovery of Predictive Biomarkers
Published in Cancer research (Chicago, Ill.) (01-03-2016)“…Many promising new cancer drugs proceed through preclinical testing and early-phase trials only to fail in late-stage clinical testing. Thus, improved models…”
Get full text
Journal Article -
10
Bryostatin-I: A dendritic cell stimulator for chemokines induction and a promising adjuvant for a peptide based cancer vaccine
Published in Cytokine (Philadelphia, Pa.) (01-12-2010)“…Bryostatin-1 (Bryo-1), a PKC modulator, was previously shown to activate monocytes and lymphocytes to produce cytokines. In this report, we investigated the…”
Get full text
Journal Article -
11
Noninvasive Imaging of Dendrimer‐Type N‐Glycan Clusters: In Vivo Dynamics Dependence on Oligosaccharide Structure
Published in Angewandte Chemie (25-10-2010)Get full text
Journal Article -
12
Abstract 4445: Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Current treatments for acute myeloid leukemia (AML) often fail to induce long-term remissions and are toxic to normal tissues, prompting the need to develop…”
Get full text
Journal Article -
13
Abstract 907: Efficacy of SAR302503, a JAK2 inhibitor, in primary human acute myeloid leukemia xenografts
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Small molecule inhibitors of Janus kinase 2 (JAK2) such as Ruxolitinib and SAR302503 have demonstrated efficacy in clinical trials for treatment of…”
Get full text
Journal Article -
14
Noninvasive Imaging of Dendrimer-Type N-Glycan Clusters: In Vivo Dynamics Dependence on Oligosaccharide Structure
Published in Angewandte Chemie (25-10-2010)“…Ganzkörperaufnahme: Eine selbstaktivierende 1,3‐dipolare Huisgen‐Cycloaddition und eine 6π‐Azaelektrocyclisierung von Lysin‐haltigen Dendrimeren (siehe Bild)…”
Get full text
Journal Article